Lexicon Pharmaceuticals, Inc. (LXRX)
2.255
+0.02
(+0.67%)
USD |
NASDAQ |
Sep 03, 16:00
2.255
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Investing (Quarterly) : -16.46M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.46M |
| March 31, 2026 | -70.26M |
| December 31, 2025 | 4.83M |
| September 30, 2025 | 52.12M |
| June 30, 2025 | 15.48M |
| March 31, 2025 | 40.58M |
| December 31, 2024 | 53.70M |
| September 30, 2024 | 53.47M |
| June 30, 2024 | -12.32M |
| March 31, 2024 | -110.22M |
| December 31, 2023 | 51.90M |
| September 30, 2023 | -39.33M |
| June 30, 2023 | -74.61M |
| March 31, 2023 | 12.09M |
| December 31, 2022 | 24.17M |
| September 30, 2022 | -77.20M |
| June 30, 2022 | -13.65M |
| March 31, 2022 | -4.408M |
| December 31, 2021 | 6.096M |
| September 30, 2021 | -0.40M |
| June 30, 2021 | 14.14M |
| March 31, 2021 | -17.72M |
| December 31, 2020 | 44.10M |
| September 30, 2020 | 215.80M |
| June 30, 2020 | 78.07M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.78M |
| December 31, 2019 | -109.40M |
| September 30, 2019 | -31.28M |
| June 30, 2019 | -7.45M |
| March 31, 2019 | -7.726M |
| December 31, 2018 | 58.75M |
| September 30, 2018 | 56.40M |
| June 30, 2018 | 47.37M |
| March 31, 2018 | 7.063M |
| December 31, 2017 | -135.77M |
| September 30, 2017 | 87.05M |
| June 30, 2017 | 56.79M |
| March 31, 2017 | 42.46M |
| December 31, 2016 | 56.46M |
| September 30, 2016 | 33.90M |
| June 30, 2016 | 61.54M |
| March 31, 2016 | -133.64M |
| December 31, 2015 | -124.14M |
| September 30, 2015 | 77.77M |
| June 30, 2015 | 0.34M |
| March 31, 2015 | -70.99M |
| December 31, 2014 | -170.72M |
| September 30, 2014 | 20.51M |
| June 30, 2014 | 1.223M |
| March 31, 2014 | 40.57M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viatris, Inc. | -51.60M |
| Pfizer Inc. | 2.106B |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.192M |
| Cash from Financing (Quarterly) | -0.512M |
| Free Cash Flow | -64.99M |
| Free Cash Flow Per Share (Quarterly) | -0.021 |
| Free Cash Flow to Equity (Quarterly) | -10.73M |
| Free Cash Flow to Firm (Quarterly) | -6.583M |
| Free Cash Flow Yield | -7.37% |